411 related articles for article (PubMed ID: 33416494)
1. Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus.
Hawman DW; Meade-White K; Leventhal S; Feldmann F; Okumura A; Smith B; Scott D; Feldmann H
Elife; 2021 Jan; 10():. PubMed ID: 33416494
[TBL] [Abstract][Full Text] [Related]
2. Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.
Hawman DW; Meade-White K; Haddock E; Habib R; Scott D; Thomas T; Rosenke R; Feldmann H
J Virol; 2019 Sep; 93(18):. PubMed ID: 31292241
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside-Modified mRNA Vaccines Protect IFNAR
Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
[TBL] [Abstract][Full Text] [Related]
4. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
J Virol; 2017 May; 91(10):. PubMed ID: 28250124
[TBL] [Abstract][Full Text] [Related]
5. New aspects about Crimean-Congo hemorrhagic fever (CCHF) cases and associated fatality trends: A global systematic review and meta-analysis.
Nasirian H
Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101429. PubMed ID: 32062190
[TBL] [Abstract][Full Text] [Related]
6. A chronological review of experimental infection studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus.
Spengler JR; Estrada-Peña A; Garrison AR; Schmaljohn C; Spiropoulou CF; Bergeron É; Bente DA
Antiviral Res; 2016 Nov; 135():31-47. PubMed ID: 27713073
[TBL] [Abstract][Full Text] [Related]
7. Crimean-Congo hemorrhagic fever.
Whitehouse CA
Antiviral Res; 2004 Dec; 64(3):145-60. PubMed ID: 15550268
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in understanding Crimean-Congo hemorrhagic fever virus.
Hawman DW; Feldmann H
F1000Res; 2018; 7():. PubMed ID: 30416710
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
[TBL] [Abstract][Full Text] [Related]
10. Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity.
Bente DA; Forrester NL; Watts DM; McAuley AJ; Whitehouse CA; Bray M
Antiviral Res; 2013 Oct; 100(1):159-89. PubMed ID: 23906741
[TBL] [Abstract][Full Text] [Related]
11. Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.
Hawman DW; Haddock E; Meade-White K; Williamson B; Hanley PW; Rosenke K; Komeno T; Furuta Y; Gowen BB; Feldmann H
Antiviral Res; 2018 Sep; 157():18-26. PubMed ID: 29936152
[TBL] [Abstract][Full Text] [Related]
12. Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy.
Zivcec M; Safronetz D; Scott D; Robertson S; Ebihara H; Feldmann H
J Infect Dis; 2013 Jun; 207(12):1909-21. PubMed ID: 23417661
[TBL] [Abstract][Full Text] [Related]
13. Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease.
Garrison AR; Smith DR; Golden JW
Viruses; 2019 Jun; 11(7):. PubMed ID: 31261754
[TBL] [Abstract][Full Text] [Related]
14. Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target.
Neogi U; Elaldi N; Appelberg S; Ambikan A; Kennedy E; Dowall S; Bagci BK; Gupta S; Rodriguez JE; Svensson-Akusjärvi S; Monteil V; Vegvari A; Benfeitas R; Banerjea A; Weber F; Hewson R; Mirazimi A
Elife; 2022 Apr; 11():. PubMed ID: 35437144
[TBL] [Abstract][Full Text] [Related]
15. Crimean-Congo haemorrhagic fever virus: Past, present and future insights for animal modelling and medical countermeasures.
Mendoza EJ; Warner B; Safronetz D; Ranadheera C
Zoonoses Public Health; 2018 Aug; 65(5):465-480. PubMed ID: 29676526
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of neutralizing and fusion inhibitory peptides to Crimean-Congo hemorrhagic fever virus.
Mears MC; Rodriguez SE; Schmitz KS; Padilla A; Biswas S; Cajimat MNB; Mire CE; Welch SR; Bergeron É; Alabi CA; Porotto M; Bente DA
Antiviral Res; 2022 Nov; 207():105401. PubMed ID: 36049554
[TBL] [Abstract][Full Text] [Related]
17. CD8
Rao D; Meade-White K; Leventhal S; Mihalakakos E; Carmody A; Feldmann H; Hawman DW
EBioMedicine; 2023 Nov; 97():104839. PubMed ID: 37866114
[TBL] [Abstract][Full Text] [Related]
18. Molecular (ticks) and serological (humans) study of Crimean-Congo hemorrhagic fever virus in the Iberian Peninsula, 2013-2015.
Palomar AM; Portillo A; Santibáñez S; García-Álvarez L; Muñoz-Sanz A; Márquez FJ; Romero L; Eiros JM; Oteo JA
Enferm Infecc Microbiol Clin; 2017; 35(6):344-347. PubMed ID: 28291670
[TBL] [Abstract][Full Text] [Related]
19. Influence of laboratory animal hosts on the life cycle of Hyalomma marginatum and implications for an in vivo transmission model for Crimean-Congo hemorrhagic fever virus.
Gargili A; Thangamani S; Bente D
Front Cell Infect Microbiol; 2013; 3():39. PubMed ID: 23971007
[TBL] [Abstract][Full Text] [Related]
20. Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.
Lindquist ME; Zeng X; Altamura LA; Daye SP; Delp KL; Blancett C; Coffin KM; Koehler JW; Coyne S; Shoemaker CJ; Garrison AR; Golden JW
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
